Oct 16, 2025 | Provider Resource
Healthy Texas Women (HTW) providers who intend to provide or continue providing HTW services during program year 2026 (January 1, 2026 – December 31, 2026) must complete the annual recertification process. The recertification window for the 2026 program year will be...
Oct 13, 2025 | Provider Resource
The purpose of this communication is to inform providers of new state requirements under House Bill (H.B.) 44 (88th Legislature, Regular Session, 2023). Effective April 29, 2025, the Texas Health and Human Services Commission (HHSC) adopted new rules that prohibit...
Sep 24, 2025 | Provider Resource
Each year, Hispanic Heritage Month (September 15 – October 15) honors the history, culture, and contributions of Latino communities in the United States. It is also a time to reflect on the unique challenges these communities face in accessing quality health care and...
Aug 28, 2025 | Provider News, Provider Resource
HHSC will begin collecting cost surveys for the state fiscal year (SFY) 2024 on September 1, 2025. The purpose of the cost survey is to collect Financial Management Services Agency (FMSA) costs for SFY 2024 for all FMSAs in Texas. This cost information will be used in...
Aug 25, 2025 | HHSC News, Provider Resource
UPDATED 9/3/2025: This news post has been edited to reflect updated guidance from HHSC. The information below applies to all Texas Medicaid clients impacted by the 2025 Texas flooding regardless of whether the clients are permanent residents of a declared disaster...
Aug 19, 2025 | Provider Resource
Inpatient high-cost clinician-administered drugs (HCCADs) are drugs or biologics that the Texas Health and Human Services Commission (HHSC) has approved to be “carved out” of the All-Patient Refined Diagnosis Related Group (APR-DRG) and can be billed on an outpatient...
